Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

Share Price is delayed by 15 minutes
Get Live Data
1.30    0.00 (0.00%)
Bid:
1.25
Ask:
1.35
Spread: 0.10 (8.00%)
Market Cap: £20.87m
GDR Live PriceLast checked at - London Stock Exchange

Intraday Genedrive Share Chart

Block Listing Returns

31 May 2023 07:00

RNS Number : 0413B
Genedrive PLC
31 May 2023
Β 

Β 

genedrive plc

("genedrive" or the "Company")

Β 

Block Listing Returns

Β 

The Company confirms the block listing six monthly return for the period to 31 May 2023.

Β 

Name of applicant

genedrive plc

Β 

Name of scheme

2007 Share Option Scheme

Β 

Period of return:

From:

01 December 2022

To:

Β 31 May 2023

Balance of unallocated securities under scheme(s) from previous return:

139,226 shares

Β 

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:Β  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

7,500 shares

Equals:Β  Balance under scheme(s) not yet issued/allotted at end of period:

131,726 shares

Β 

Β 

In order to co-terminate future block listing returns the Company confirms the following returns for the two block listings granted earlier in the month.

Β 

Name of applicant

genedrive plc

Β 

Name of scheme

2017 Share Option Scheme

Β 

Period of return:

From:

19 May 2023

To:

Β 31 May 2023

Balance of unallocated securities under scheme(s) from previous return:

1,150,588 shares

Β 

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:Β  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:Β  Balance under scheme(s) not yet issued/allotted at end of period:

1,150,588 shares

Β 

Β 

Name of applicant

genedrive plc

Β 

Name of scheme

Unapproved Share Option Scheme

Β 

Period of return:

From:

19 May 2023

To:

Β 31 May 2023

Balance of unallocated securities under scheme(s) from previous return:

2,668,144 shares

Β 

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:Β  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:Β  Balance under scheme(s) not yet issued/allotted at end of period:

2,668,144 shares

Β 

Name of contact:

Russ Shaw CFO

Telephone number of contact:

+44 (0)161 989 0245

Β 

For enquires:

Β 

genedrive plc

+44 (0)161 989 0245

David Budd: CEO /Β Russ Shaw: CFO

Peel Hunt LLPΒ (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

James Steel / Oliver Duckworth

finnCap (Joint Broker)

+44 (0)20 7220 500

Geoff Nash / George Dollemore / Nigel Birks / Alice Lane

Walbrook PR LtdΒ (Media Relations & Investor Relations)

+44 (0)20 7933 8780 orΒ genedrive@walbrookpr.com

Paul McManusΒ /Β Anna Dunphy

+44 (0)7980 541 893 / +44 (0)7876 741 001

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BLRFLFILETIIVIV
Date   Source Headline
27th May 20227:00 amRNSBlock listing Interim Review
25th Apr 20229:05 amRNSSecond Price Monitoring Extn
25th Apr 20229:00 amRNSPrice Monitoring Extension
20th Apr 20222:00 pmRNSPrice Monitoring Extension
8th Apr 20224:41 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
4th Apr 20225:13 pmRNSDirector/PDMR Shareholding
4th Apr 202211:05 amRNSSecond Price Monitoring Extn
4th Apr 202211:00 amRNSPrice Monitoring Extension
4th Apr 20229:05 amRNSSecond Price Monitoring Extn
4th Apr 20229:00 amRNSPrice Monitoring Extension
31st Mar 20229:05 amRNSSecond Price Monitoring Extn
31st Mar 20229:00 amRNSPrice Monitoring Extension
29th Mar 202211:06 amRNSSecond Price Monitoring Extn
29th Mar 202211:00 amRNSPrice Monitoring Extension
29th Mar 202210:00 amRNSNICE issues Medtech Innovation Briefing
29th Mar 20227:00 amRNSHalf-year Report
25th Mar 202211:05 amRNSSecond Price Monitoring Extn
25th Mar 202211:00 amRNSPrice Monitoring Extension
24th Mar 20222:00 pmRNSPrice Monitoring Extension
22nd Mar 20224:41 pmRNSSecond Price Monitoring Extn
22nd Mar 20224:36 pmRNSPrice Monitoring Extension
21st Mar 20223:16 pmRNSPALOH study results published in JAMA Pediatrics
21st Mar 20229:05 amRNSSecond Price Monitoring Extn
21st Mar 20229:00 amRNSPrice Monitoring Extension
18th Mar 20224:41 pmRNSSecond Price Monitoring Extn
18th Mar 20224:36 pmRNSPrice Monitoring Extension
18th Mar 20222:05 pmRNSSecond Price Monitoring Extn
18th Mar 20222:00 pmRNSPrice Monitoring Extension
18th Mar 20222:00 pmRNSFirst NHS Deployments of Genedrive System for AIHL
17th Mar 20227:00 amRNSBoard appointment
16th Mar 20224:41 pmRNSSecond Price Monitoring Extn
16th Mar 20224:35 pmRNSPrice Monitoring Extension
2nd Mar 20227:00 amRNSFurther re Directorate Change
23rd Feb 20225:00 pmRNSDirector/PDMR Shareholding
23rd Feb 20229:05 amRNSSecond Price Monitoring Extn
23rd Feb 20229:00 amRNSPrice Monitoring Extension
23rd Feb 20227:00 amRNSUpdate on Point of Care Covid Test
15th Feb 20222:01 pmRNSPrice Monitoring Extension
4th Feb 20227:00 amRNSNotice of Results
21st Jan 202211:05 amRNSSecond Price Monitoring Extn
21st Jan 202211:00 amRNSPrice Monitoring Extension
20th Jan 20224:40 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
10th Jan 20229:06 amRNSSecond Price Monitoring Extn
10th Jan 20229:00 amRNSPrice Monitoring Extension
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:01 pmRNSPrice Monitoring Extension
30th Dec 202111:20 amRNSResult of AGM
30th Dec 20219:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.